Azurity Pharmaceuticals
Kelly Dingle is an experienced pharmaceutical professional currently serving as the Director of Trade & Specialty Channel Management at Azurity Pharmaceuticals since April 2024. Dingle's previous roles include Senior Director of Specialty Channel Access at Amgen, where responsibilities encompassed the establishment of a new strategic business unit focused on profitability and market access contracts. Prior to Amgen, Dingle held key positions at Horizon Therapeutics, Coherus BioSciences, Sandoz, Pfizer, and MedImmune, contributing to the success of renowned companies in the specialty and biopharmaceutical sectors. Dingle holds a bachelor's degree from Illinois State University.
This person is not in any teams
This person is not in any offices